Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 25

1.

Evaluation of in-house genotyping assay performance using dried blood spot specimens in the Global World Health Organization laboratory network.

Parkin N, de Mendoza C, Schuurman R, Jennings C, Bremer J, Jordan MR, Bertagnolio S; WHO DBS Genotyping Working Group..

Clin Infect Dis. 2012 May;54 Suppl 4:S273-9. doi: 10.1093/cid/cir982.

2.

Optimization of a low cost and broadly sensitive genotyping assay for HIV-1 drug resistance surveillance and monitoring in resource-limited settings.

Zhou Z, Wagar N, DeVos JR, Rottinghaus E, Diallo K, Nguyen DB, Bassey O, Ugbena R, Wadonda-Kabondo N, McConnell MS, Zulu I, Chilima B, Nkengasong J, Yang C.

PLoS One. 2011;6(11):e28184. doi: 10.1371/journal.pone.0028184. Epub 2011 Nov 23.

3.

Development and application of a broadly sensitive dried-blood-spot-based genotyping assay for global surveillance of HIV-1 drug resistance.

Yang C, McNulty A, Diallo K, Zhang J, Titanji B, Kassim S, Wadonda-Kabondo N, Aberle-Grasse J, Kibuka T, Ndumbe PM, Vedapuri S, Zhou Z, Chilima B, Nkengasong JN.

J Clin Microbiol. 2010 Sep;48(9):3158-64. doi: 10.1128/JCM.00564-10. Epub 2010 Jul 21.

4.

Prevalence of drug resistance and importance of viral load measurements in Honduran HIV-infected patients failing antiretroviral treatment.

Murillo W, de Rivera IL, Parham L, Jovel E, Palou E, Karlsson AC, Albert J.

HIV Med. 2010 Feb;11(2):95-103. doi: 10.1111/j.1468-1293.2009.00747.x. Epub 2009 Aug 3.

5.

Antiretroviral resistance among HIV type 1-infected women first exposed to antiretrovirals during pregnancy: plasma versus PBMCs.

Soto-Ramirez LE, Rodriguez-Diaz R, Durán AS, Losso MH, Salomón H, Gómez-Carrillo M, Pampuro S, Harris DR, Duarte G, De Souza RS, Read JS; NISDI Perinatal Study Group..

AIDS Res Hum Retroviruses. 2008 Jun;24(6):797-804. doi: 10.1089/aid.2007.0246.

6.

Prevalence of resistance mutations in HIV-1-Infected Hondurans at the beginning of the National Antiretroviral Therapy Program.

Lloyd B, O'Connell RJ, Michael NL, Aviles R, Palou E, Hernandez R, Cooley J, Jagodzinski LL.

AIDS Res Hum Retroviruses. 2008 Apr;24(4):529-35. doi: 10.1089/aid.2007.0172.

PMID:
18366313
7.

Dynamics of drug-resistant HIV-1 in plasma and peripheral blood cells in patients during and after enfuvirtide therapy.

Poveda E, Briz V, Paraskevis D, Barreiro P, Hatzakis A, Soriano V.

AIDS Res Hum Retroviruses. 2007 Sep;23(9):1078-82.

PMID:
17919101
8.
9.

Antiretroviral drug therapy alters the profile of human immunodeficiency virus type 1-specific T-cell responses and shifts the immunodominant cytotoxic T-lymphocyte response from Gag to Pol.

Karlsson AC, Chapman JM, Heiken BD, Hoh R, Kallas EG, Martin JN, Hecht FM, Deeks SG, Nixon DF.

J Virol. 2007 Oct;81(20):11543-8. Epub 2007 Aug 1.

10.

Long-term persistence of transmitted HIV drug resistance in male genital tract secretions: implications for secondary transmission.

Smith DM, Wong JK, Shao H, Hightower GK, Mai SH, Moreno JM, Ignacio CC, Frost SD, Richman DD, Little SJ.

J Infect Dis. 2007 Aug 1;196(3):356-60. Epub 2007 Jun 19.

PMID:
17597449
11.
12.

MEGA4: Molecular Evolutionary Genetics Analysis (MEGA) software version 4.0.

Tamura K, Dudley J, Nei M, Kumar S.

Mol Biol Evol. 2007 Aug;24(8):1596-9. Epub 2007 May 7.

PMID:
17488738
13.

Genotypic resistance in plasma and peripheral blood lymphocytes in a group of naive HIV-1 patients.

Bon I, Gibellini D, Borderi M, Alessandrini F, Vitone F, Schiavone P, Re MC.

J Clin Virol. 2007 Apr;38(4):313-20. Epub 2007 Feb 15.

PMID:
17306618
14.

Analysis of a long-term discrepancy in drug-targeted genes in plasma HIV-1 RNA and PBMC HIV-1 DNA in the same patient.

Usuku S, Noguchi Y, Sakamoto M, Adachi T, Sagara H, Sudo K, Nishizawa M, Kondo M, Tochikubo O, Imai M.

Jpn J Infect Dis. 2006 Apr;59(2):122-5.

15.

Assessment of drug resistance mutations in plasma and peripheral blood mononuclear cells at different plasma viral loads in patients receiving HAART.

Chew CB, Potter SJ, Wang B, Wang YM, Shaw CO, Dwyer DE, Saksena NK.

J Clin Virol. 2005 Jul;33(3):206-16. Epub 2004 Dec 24.

PMID:
15911442
16.

Drug-associated resistance mutations in plasma and peripheral blood mononuclear cells of human immunodeficiency virus type 1-infected patients for whom highly active antiretroviral therapy is failing.

Sarmati L, Nicastri E, Uccella I, D'Ettorre G, Parisi SG, Palmisano L, Galluzzo C, Concia E, Vullo V, Vella S, Andreoni M.

J Clin Microbiol. 2003 Apr;41(4):1760-2.

17.

Mutational patterns of paired blood and rectal biopsies in HIV-infected patients on HAART.

Monno L, Punzi G, Scarabaggio T, Saracino A, Brindicci G, Fiore JR, Iambrenghi OC, Di Stefano M, Pastore G, Angarano G.

J Med Virol. 2003 May;70(1):1-9.

PMID:
12629636
18.

A simple and sensitive 'in-house' method for determining genotypic drug resistance in HIV-1.

Lindström A, Albert J.

J Virol Methods. 2003 Jan;107(1):45-51.

PMID:
12445937
19.

Drug resistance testing in PBMCs of HIV infected patients.

Tagliaferro L, Menegazzi P, Cataldini S, De Simone M, Chiriacò P, Varnier OE.

New Microbiol. 2001 Oct;24(4):325-32.

PMID:
11718369
20.

Analysis of HIV drug-resistant quasispecies in plasma, peripheral blood mononuclear cells and viral isolates from treatment-naive and HAART patients.

Paolucci S, Baldanti F, Campanini G, Zavattoni M, Cattaneo E, Dossena L, Gerna G.

J Med Virol. 2001 Oct;65(2):207-17.

PMID:
11536225

Supplemental Content

Support Center